Welcome : Guest

Transgenomic, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Transgenomic, Inc., which is principally a Biotechnology Company. Illustrated with 93 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-44627
Price: $3500
Company Type: Public
Pages: 95
Date: November 2016
Market Data Tables: 93

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Biotechnology......3
Table 1: Biotechnology Market by Category in China (2015) - Percentage Share Breakdown by Value for Biopharmaceutical and Chemical......3
Table 2: Biotechnology Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Biopharmaceutical and Chemical......4
Biotesting (Outsourced)......5
Table 3: Outsourced Biotesting Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Environment, Pharma and Others......5
Biotechnology Drugs......6
Table 4: Biotechnology Drugs by Type Worldwide (2015) - Percentage Market Share Breakdown by Value for Cell Therapy, Gene Therapy, Monoclonal Antibodies (MAB), Recombinant Hormones and Proteins, Vaccines, and Others......6
Cancer Drugs......7
Table 5: Oncology/Hematology Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Cell Factors, Chemopreventatives, Chemotherapeutics, Mabs, Targeted Therapies, and Others......7
Table 6: Oncology Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for European Union Five, Japan, US and Others......8
Cancer Market......9
Table 7: Cancer Care Expenditure by Site Worldwide (2015) - Percentage Share Breakdown for Breast, Colorectal, Lymphoma, Lung, Prostate and Others*......9
Table 8: Cancer Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Heme, Lung, Prostate, and Others......10
Table 9: Oncology Market by Cancer Type Worldwide (2015) - Percentage Share Breakdown by Value for Breast Cancer, Metastatic Colorectal Cancer, Non-Small Cell Lung Cancer, and Others......11
Table 10: Clinical Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......12
Table 11: Hereditary Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......13
Table 12: Cancer Market by Type in China (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Esophagus, Liver, Lung, Stomach and Others......14
Table 13: Oncology Market by Category in China (2015) - Percentage Share Breakdown by Value for Anti- Tumor Agents, Hormone Therapy, Immuno Suppresants and Immunostimulants......15
Table 14: Oncology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Solid Tumor and Others......16
Table 15: Pharmacogenomics Research by Cancer Type in the US (2015) - Percentage Market Share Breakdown by Value for Brain, Breast and Leukemia, Colon, Colon, Leukemia, Lung and Pancreatic, Colon, Leukemia, Thyroid, and Ovary, Colon, Melanoma, and Ovary, Gastrointestinal, Leukemia, and Lung......17
Cancer Patients......18
Table 16: Breast Cancer Diagnoses by Hospital Type in the US (2015) - Percentage Share Breakdown by Volume for Community, Comprehensive, Teaching and Research, and Others......18
Table 17: No. of Colorectal Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......19
Table 18: No. of Invasive Breast Cancer Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......20
Table 19: No. of Primary Liver Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......21
Table 20: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Imbruvica PCYC, Rituxan, Gazyva ROG, and Others......22
Table 21: No. of Cutaneous Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......23
Table 22: No. of Ocular Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......24
Table 23: Female Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Lung, Breast, Colon, Rectum and Anus, Intestine, Liver, and Others......25
Table 24: Male Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Colon, Colon, Rectum and Anus, Intestine, Liver, Lung, and Others......26
Table 25: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category in European Union (2015) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......27
Table 26: No. of Chronic Lymphocytic Leukemia (CLL) (R/R) Patients by Category in European Union (2015) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......28
Table 27: No. of Cancer Patients by Type in the US (2015) - Percentage Market Share Breakdown for Colorectal Cancer (CRC), Melanoma, Non-Squamous Non-Small-Cell Lung Cancer (NSCLC), Ovarian, Prostate, Renal Cell Carcinoma (RCC), and Squamous Non-Small-Cell Lung Cancer (NSCLC)......29
Table 28: Number of Cancer Patients by Type in the US (2015) - Percentage Share Breakdown by Volume for Bladder Cancer, Breast Cancer (Female), Colon and Rectum Cancer, Endometrial Cancer, Kidney and Renal Pelvis Cancer, Lung and Bronchus Cancer, Melanoma of the Skin, Non-Hodgkin Lymphoma, Prostate Cancer, and Thyroid Cancer......30
Table 29: No. of Cancer Patients Death by Type in the US (2015) - Percentage Share Breakdown for Breast, Colorectal, Lung, Melanoma, and Prostate......31
Table 30: New Patients with Cancer by Site in the US (2015) - Percentage Market Share Breakdown by volume for Colorectal, Lung and Bronchus, Melanoma, Pancreas, and Others......32
Table 31: Number of Cancer Patients by Type Worldwide (2015) - Percentage Share Breakdown by Volume for Bladder, Breast, Cervix Uteri, Colorectum, Liver, Lung, Non-Hodgkin lymphoma, Oesophagus, Prostate, and Stomach......33
Table 32: No. of Bladder Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Invasive Patients, and Non-Invasive Patients......34
Table 33: No. of Invasive Breast Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......35
Table 34: New Patients with Cancer in Stage 3/4 by Site in the US (2015) - Percentage Market Share Breakdown by Volume for Colorectal, Lung and Bronchus, Pancreas and Others......36
Table 35: No. of Solid Cancer Tumor Patients by Type Worldwide (2015) - Percentage Share Breakdown for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......37
Table 36: No. of Non Small Cell Lung Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I, Stage II-III, Stage III-IV, and Undiagnozed......38
Cervical Cancer......39
Table 37: Cervical Cancer Market by HPV Type in England (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 33, HPV 45, and Others......39
Table 38: Cervical Cancer Market by HPV Type in Europe (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 31, HPV 33, and Others......40
Hematological Cancer......41
Table 39: Hematological Cancer by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), and Non-Hodgkin’s Lymphoma (NHL)......41
Skin Cancer......42
Table 40: Skin Cancer by Type Worldwide (2015) - Percentage Market Share Breakdown by Volume for Basal Cell Carcinomas, Melanoma, and Squamous Cell Carcinomas......42
Cancer-Associated Mucositis......43
Table 41: Cancer-Associated Mucositis Market by Activity Worldwide (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Head and Neck, Non-Small Cell Lung cancer and Others......43
Chronic Myelogenous Leukemia (CML)......44
Table 42: Chronic Myelogenous Leukemia (CML) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Asia-Pacific, Canada, European Union, Japan, USA, and Others......44
Multiple Myeloma......45
Table 43: Multiple Myeloma by Age Group Worldwide (2015) - Percentage Share Breakdown by No. of New Cases for 45-54, 55-64, 65-74, 75-84, >84, and Others......45
Table 44: Multiple Myeloma Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Kyprolis AMGN, Pomalyst CELG, Revlimid CELG, Thalomid CELG, and Velcade TKD/JNJ......46
Oncology Genomics......47
Table 45: Oncology Genomics Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Clinical, Hereditary, and Molecular Monitoring......47
Table 46: Oncology Genomics (Clinical, Hereditary, and Molecular Monitoring) Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......48
Table 47: Oncology Genomics Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Clinical, Hereditary, and Molecular Monitoring......49
Molecular Diagnostics......50
Table 48: Molecular Diagnostics Market by Application Worldwide (2015) - Percentage Share Breakdown by Value for Blood Screening, Genetics, Infectious Disease, Oncology and Others......50
Table 49: Global Molecular Diagnostics (MDx) Market by Infectious Diseases Therapeutic Area (2015) - Percentage Share Breakdown by Value Sales for CT/NG, Healthcare-associated Infections (HAI), Hepatitis, HIV, Respiratory and Others......51
Table 50: Global Molecular Diagnostics (MDx) Market by Region (2015) - Percentage Breakdown by Value Sales for Americas, EMEA and Pacific......52
Table 51: Molecular Diagnostic Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Disease Inherited, Infectious Diseases, Oncology, Prenatal, and Tissue Typing......53
Table 52: Molecular Diagnostics (MDx) Market by Location of Test Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Banks, Hospitals, Near-Patient, and Reference Labs......54
Table 53: Molecular Diagnostics (MDx) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Bacteriology, Blood Screening, Genomics and Virology......55
Table 54: Molecular Diagnostics (MDx) Market by Technology Worldwide (2015) - Percentage Share Breakdown by Value Sales for Beads, CE Sequencing, Hybrid Capture, ISH, Microarrays, NGS, PCR, Qpcr, TMA, and Others......56
Table 55: Molecular Diagnostics (MDx) Market by Therapeutic Area Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Screening, CT / NG, HAIs, HLA, HPV, Oncology, Viral Load, and Others......57
Table 56: Molecular Diagnostics (MoDx) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Europe, Japan, Korea, US, and Others......58
Table 57: Molecular Diagnostics Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Biochip and Lab-on-a-Chip (LOAC), In Situ Hybridization (ISH), Microarrays, Polymerase Chain Reaction (PCR) and Others......59
Table 58: Molecular Diagnostics Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Infectious Diseases, Inherited Disease, Oncology, Prenatal and Tissue Typing......60
Table 59: Molecular Diagnostics Infectious Diseases Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Active Tuberculosis, Blood Banking, Chlamydia trachomatis (CT), and Neisseria gonorrhoeae (NG), Clostridium difficile, Human Papillomavirus (HPV), Influenza, Panels, S. aureus (SA), and methicillin-resistant S. aureus (MRSA), Viral Load, and Others......61
Table 60: Molecular Diagnostics Test Market by Type in Europe (2015) - Percentage Share Breakdown by Volume for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), Methicillin-resistant Staphylococcus aureus (MRSA) and Others......62
Table 61: Spending on Molecular Diagnostics and Genetic Testing by Payer in the US (2015) - Percentage Market Share Breakdown by Value for Cancer, Infectious Diseases, Inhired Conditions and Other......63
Table 62: Molecular Diagnostics Lab Market by Test Complexity in the US (2015) - Percentage Share Breakdown by Volume for Highly Complex w/LDT, Highly Complex, no LDT and Moderately Complex......64
Table 63: Molecular Diagnostics Lab Market by Test Type in the US (2015) - Percentage Share Breakdown by Volume for Both ID & Genetics, Disease, Only and Infectious......65
Table 64: Molecular Diagnostics Market by Segment in the US (2015) - Percentage Share Breakdown by Value Sales for Blood Screening, Genetic Testing Order, Oncology, Virology and Other Infectious Diseases......66
Table 65: Molecular Diagnostic Genetics Laboratories Market by Assay in the US (2015) - Percentage Share Breakdown by Value Sales for Cystic Fibrosis, Epidermal Growth Factor Receptor (EGFR), Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS Gene) and Others......67
Table 66: Number of Molecular Diagnostics Laboratories by CLIA Complexity in the US (2015) - Percentage Market Share Breakdown for Highly Complex, No Laboratory-Developed Test (LDT), Highly Complex, With Laboratory-Developed Test (LDT) and Moderately Complex......68
Table 67: Number of Molecular Diagnostics Laboratories by Testing Type in the US (2015) - Percentage Market Share Breakdown for Genetics Only, Infectious Disease Only and Both Infectious Disease and Genetics......69
Molecular Cystic Fibrosis (CF) Testing......70
Table 68: Molecular Cystic Fibrosis (CF) Testing Market by Assay in the US (2015) - Percentage Share Breakdown by Value Sales for Cystic Fibrosis Genotyping, eSensor® Cystic Fibrosis, InPlex® Cystic Fibrosis (CF), Laboratory Developed Tests and xTAG® Cystic Fibrosis......70
Molecular Infectious Disease Testing......71
Table 69: Molecular Infectious Disease Market by Panel Worldwide (2015) - Percentage Share Breakdown by Value Sales for BSI +/- (Sepsis), CSF, Enteric (GI), Fungal (Candida), HCV Genotyping, Respiratory, and STI......71
Table 70: Molecular Infectious Disease Diagnostic Equipment Market by Platform Worldwide (2015) - Percentage Share Breakdown by Value Sales for BioFire, LX 100/200 & MAGPIX, MALDI Biotyper, Verigene, XT-8, and Others......72
Molecular Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing......73
Table 71: Molecular Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market by Type in the US (2015) - Percentage Share Breakdown by Value Sales for Chromogenic Media, Conventional Media, GeneXpert, GneOhm, LightCycler and Molecular Diagnostics Laboratory-Developed Test (MDX LDT)......73
Molecular Monitoring Oncology......74
Table 72: Molecular Monitoring Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......74
Biotechnology......75
Table 73: Market Shares of Leading Biotechnology Companies Worldwide (2015) - Percentage Breakdown by Value for Amgen, Inc., Merck KGaA, Monsanto Company, Roche Holding AG, Syngenta AG, and Others......75
Table 74: Market Shares of Leading Agricultural Biotechnology Companies Worldwide (2015) - Percentage Breakdown by Research and Development (R&D) Expenditure for Bayer CropScience AG, Dow AgroSciences LLC, DuPont Pioneer, Monsanto Co., Inc., Syngenta AG and OtherS......76
Table 75: Market Shares of Leading Biotechnology Companies in China (2015) - Percentage Share Breakdown by Value for F. Hoffmann-La Roche Ltd., MERCK SERONO CO., LTD., Novo Nordisk A/S, Qilu Pharmaceutical Co., Ltd. and Others......77
Outsourced Biotesting......78
Table 76: Market Shares of Leading Outsourced Biotesting Companies Worldwide (2015) - Percentage Share Breakdown by Value for Eurofins Scientific, SGS S.A. and Others......78
Colony-Stimulating Factor (GCSF)......79
Table 77: Market Shares of Leading Granulocyte Colony-Stimulating Factor (GCSF) Companies in China (2014) - Percentage Share Breakdown by Value for Amoytop Biotech Co., Ltd., Harbin Pharmaceutical Group Co., Ltd., Kyowa Hakko Kirin Co., Ltd., Qilu pharmaceutical Co., Ltd., Zhejiang Huahai Pharmaceutical Co., Ltd., and Others......79
Cancer Drugs......80
Table 78: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......80
Table 79: Market Shares of Leading Oncology/Hematology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......81
Table 80: Market Shares of Leading Oncology Drug Manufacturers in China (2015) - Percentage Share Breakdown by Value for Astrazeneca, Jiangsu Hengrui Medicine Co., Ltd., Roche Group and Others......82
Table 81: Anti-Cancer Drugs Market by Product Type in China (2015) - Percentage Share Breakdown by Value for Anastrozole, Capecitabine, Cetuximab, Compound kushen, Docetaxel, Epirubicin, Erlotinib, Gefitinib, Gemcitabine, Goserelin, Interferon α-2a, Interferon α-2b, Irinotecan, Kangai, Lentinan, Letrozole, Oxaliplatin, Paclitaxel, Pemetrexed, Pidotimod, RhG-CSF, RhIL-2, Rituximab, Sorafenib, Sshenqi Fuzheng, Thymopentin, Thymosin a1, Trastuzmmab, Triptorelin, TS-1, and Others......83
Table 82: Anti-Cancer Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value for Alkylating Agents, Antibiotics, Antimetabolites, Hormonal Agents, Immunostimulant, Plant Alkaloids, and Others......84
Breast Cancer Drugs......85
Table 83: Market Shares of Leading Breast Cancer Drugs by Value Sales in China (2014) - Percentage Breakdown for Alkylating Agents, Antimetabolite, Antitumor Antibiotics, Antitumor Antihormone, Antitumor Botanicals, Monoclonal Antibodies, Targeted Small Molecule Agents, and Others......85
Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL)......86
Table 84: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Others......86
Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL)......87
Table 85: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Others......87
Table 86: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma (R/R- aNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib and Other......88
Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Testing......89
Table 87: Market Shares of Leading Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Testing Providers in the US (2014) - Percentage Breakdown by Value Sales for Abbott Laboratories, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Hologic, Inc., and Qiagen NV......89
Molecular Clostridium Difficile (C. Diff) Testing......90
Table 88: Market Shares of Leading Molecular Clostridium Difficile (C. Diff) Testing Providers the US (2014) - Percentage Breakdown by Value Sales for Becton, Dickinson and Company, Cepheid, Inc., Hologic Gen-Probe, Inc., Meridian Bioscience, Inc. and Others......90
Molecular Diagnostics......91
Table 89: Market Shares of Leading Molecular Diagnostic Product Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Abbott Laboratories, Bayer AG, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Hologic Corporation, Novartis International AG, Qiagen, and Others......91
Table 90: Market Shares of Leading Molecular Diagnostics (MDx) Companies by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories, Becton, Dickinson and Co., Cepheid, F. Hoffmann-La Roche Ltd., Hologic Gen-Probe, Inc., Novartis AG, Qiagen N.V., Siemens AG and Others......92
Table 91: Market Shares of Leading Molecular Diagnostics (MDx) Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories, Becton, Dickinson and Company, Cepheid, Inc., Hologic, Inc., Illumina, Inc., Qiagen N.V., Rogers Corporation, Siemens AG, Thermo Fisher Scientific, and Others......93
Table 92: Transgenomic, Inc.'s Sales by Segment in the US (2015) - Percentage Market Share Breakdown by Value for Instruments, Lab Services......94
Table 93: Transgenomic, Inc.’s Sales by Geographic Region Worldwide (2013) in Percentage for United States, Italy, Germany, United Kingdom, France and All Other Countries......95